James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

RadioShack Is Dead, and Salus Capital Is Playing ‘Weekend at Bernie’s’

The fine print of a $500 million loan offer should steer investors away from RadioShack stock ... not toward it.

Why GoPro, Goodyear Tire & Rubber and Buckle Are 3 of Today’s Worst Stocks

GoPro, Goodyear Tire & Rubber and Buckle dipped deep into the red ink on Tuesday, and (mostly) for good reasons.

Why SanDisk, Tiffany and Tenet Healthcare Are 3 of Today’s Worst Stocks

SanDisk, Tiffany and Tenet Healthcare all got upended Monday by warnings and alarming outlooks

5 Biotech Stocks With Explosive Drug Pipelines

For many biotech stocks, drug pipelines -- not trailing results -- determine their actual value. That's good news for investors in these 5 biotechs.

Why Apollo Education Group, Insulet and GoPro Are 3 of Today’s Worst Stocks

GoPro, Apollo Education Group and Insulet Corporation all missed out on Thursday's almost-marketwide rally. Here's the deal.